Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04612101 · ClinicalTrials.gov registry record
Check Brain Temp Trial
A clinical trial, sponsored by OSF Healthcare System.
- Completed
- Registry status
- 12
- Enrollment target
NCT04612101: Completed study, sponsored by OSF Healthcare System.
NCT04612101 is a clinical trial that has completed, run by OSF Healthcare System. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04612101 has completed, sponsored by OSF Healthcare System.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
Despite some controversial results, many patients and animal studies have suggested significant benefit of using hypothermia treatment in stroke patient population. However, certain questions for how to applying this therapy properly such as when to start, what is the optimal temperature, how long is the duration, and what is the best hypothermia technology that may avoid the complications including focal soft tissue injuries are still remain questioned. In this study, we will utilize the linear relationship of temperature vs. chemical shift in MR Spectroscopy to measure the brain temperatures in normal men.
Primary Outcome
Brian temperatures were measured at region of interests
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2020-10-01 |
What the finished NCT04612101 record still lists
NCT04612101 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04612101 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04612101 about?
NCT04612101 is a clinical study titled "Check Brain Temp Trial". Despite some controversial results, many patients and animal studies have suggested significant benefit of using hypothermia treatment in stroke patient population. However, certain questions for how to applying this therapy properly such as when to start, what is the optimal temperature, how long i...
What is the current status of trial NCT04612101?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2018-10-01. Estimated completion is 2020-10-01.
Who is sponsoring clinical trial NCT04612101?
This trial is sponsored by OSF Healthcare System, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI